USP8 Is a Novel Target for Overcoming Gefitinib Resistance in Lung Cancer von BYUN, Sanguine, LEE, Sung-Young, BODE, Ann M, KI WON LEE, ZIGANG DONG, JIHOON LEE, JEONG, Chul-Ho, FARRAND, Lee, LIM, Semi, REDDY, Kanamata, JI YOUNG KIM, LEE, Mee-Hyun, HYONG JOO LEE

Volltext

A novel HSP90 inhibitor targeting the C-terminal domain attenuates trastuzumab resistance in HER2-positive breast cancer von Park, Jung Min, Kim, Yoon-Jae, Park, Soeun, Park, Minsu, Farrand, Lee, Nguyen, Cong-Truong, Ann, Jihyae, Nam, Gibeom, Park, Hyun-Ju, Lee, Jeewoo, Kim, Ji Young, Seo, Jae Hong

Volltext

Piceatannol Enhances Cisplatin Sensitivity in Ovarian Cancer via Modulation of p53, X-linked Inhibitor of Apoptosis Protein (XIAP), and Mitochondrial Fission von Farrand, Lee, Byun, Sanguine, Kim, Ji Young, Im-Aram, Akechai, Lee, Jihoon, Lim, Semi, Lee, Ki Won, Suh, Jeong-Yong, Lee, Hyong Joo, Tsang, Benjamin K.

Volltext

Suppression of TNBC metastasis by doxazosin, a novel dual inhibitor of c-MET/EGFR von Kim, Seongjae, Park, Jung Min, Park, Soeun, Jung, Eunsun, Ko, Dongmi, Park, Minsu, Seo, Juyeon, Nam, Kee Dal, Kang, Yong Koo, Lee, Kyoungmin, Farrand, Lee, Kim, Yoon-Jae, Kim, Ji Young, Seo, Jae Hong

Volltext

β-Escin overcomes trastuzumab resistance in HER2-positive breast cancer by targeting cancer stem-like features von Park, Soeun, Park, Jung Min, Park, Minsu, Ko, Dongmi, Kim, Seongjae, Seo, Juyeon, Nam, Kee Dal, Jung, Eunsun, Farrand, Lee, Kim, Yoon-Jae, Kim, Ji Young, Seo, Jae Hong

Volltext

FDA regulatory considerations for oncology drug development von Moon, Hanlim, Zang, Dae Young, Ryu, Min‐Hee, Seo, YeonSook, Oh, Bitna, Hwang, Sunjin, Farrand, Lee

Volltext

An improved quantitative approach for the assessment of mitochondrial fragmentation in chemoresistant ovarian cancer cells von Farrand, Lee, Kim, Ji Young, Im-Aram, Akechai, Suh, Jeong-Yong, Lee, Hyong Joo, Tsang, Benjamin K

Volltext

The mTORC2 component rictor contributes to cisplatin resistance in human ovarian cancer cells von Im-aram, Akechai, Farrand, Lee, Bae, Seung-Min, Song, Gwonhwa, Song, Yong Sang, Han, Jae Yong, Tsang, Benjamin K

Volltext

The C-terminal HSP90 inhibitor NCT-58 kills trastuzumab-resistant breast cancer stem-like cells von Park, Soeun, Kim, Yoon-Jae, Park, Jung Min, Park, Minsu, Nam, Kee Dal, Farrand, Lee, Nguyen, Cong-Truong, La, Minh Thanh, Ann, Jihyae, Lee, Jeewoo, Kim, Ji Young, Seo, Jae Hong

Volltext

Flubendazole elicits anti‐metastatic effects in triple‐negative breast cancer via STAT3 inhibition von Oh, Eunhye, Kim, Yoon‐Jae, An, Hyunsook, Sung, Daeil, Cho, Tae‐Min, Farrand, Lee, Jang, Seojin, Seo, Jae Hong, Kim, Ji Young

Volltext

Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer von Kim, Yoon-Jae, Sung, Daeil, Oh, Eunhye, Cho, Youngkwan, Cho, Tae-Min, Farrand, Lee, Seo, Jae Hong, Kim, Ji Young

Volltext

Ebastine impairs metastatic spread in triple-negative breast cancer by targeting focal adhesion kinase von Seo, Juyeon, Park, Minsu, Ko, Dongmi, Kim, Seongjae, Park, Jung Min, Park, Soeun, Nam, Kee Dal, Farrand, Lee, Yang, Jinsol, Seok, Chaok, Jung, Eunsun, Kim, Yoon-Jae, Kim, Ji Young, Seo, Jae Hong

Volltext

A novel HSP90 inhibitor SL-145 suppresses metastatic triple-negative breast cancer without triggering the heat shock response von Kim, Ji Young, Cho, Tae-Min, Park, Jung Min, Park, Soeun, Park, Minsu, Nam, Kee Dal, Ko, Dongmi, Seo, Juyeon, Kim, Seongjae, Jung, Eunsun, Farrand, Lee, Nguyen, Cong-Truong, Hoang, Van-Hai, Thanh La, Minh, Ann, Jihyae, Nam, Gibeom, Park, Hyun-Ju, Lee, Jeewoo, Kim, Yoon-Jae, Seo, Jae Hong

Volltext

Sulforaphene suppresses growth of colon cancer-derived tumors via induction of glutathione depletion and microtubule depolymerization von Byun, Sanguine, Shin, Seung Ho, Park, Jiman, Lim, Semi, Lee, Eunjung, Lee, Chaeyoon, Sung, Dongeun, Farrand, Lee, Lee, Seoung Rak, Kim, Ki Hyun, Dong, Zigang, Lee, Sam W., Lee, Ki Won

Volltext

C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition von Cho, Tae-Min, Kim, Ji Young, Kim, Yoon-Jae, Sung, Daeil, Oh, Eunhye, Jang, Seojin, Farrand, Lee, Hoang, Van-Hai, Nguyen, Cong-Truong, Ann, Jihyae, Lee, Jeewoo, Seo, Jae Hong

Volltext

Molecular determinants of ovarian cancer chemoresistance: new insights into an old conundrum von Ali, Ahmed Y., Farrand, Lee, Kim, Ji Young, Byun, Sanguine, Suh, Jeong-Yong, Lee, Hyong Joo, Tsang, Benjamin K.

Volltext

The HSP90 inhibitor HVH-2930 exhibits potent efficacy against trastuzumab-resistant HER2-positive breast cancer von Park, Minsu, Jung, Eunsun, Park, Jung Min, Park, Soeun, Ko, Dongmi, Seo, Juyeon, Kim, Seongjae, Nam, Kee Dal, Kang, Yong Koo, Farrand, Lee, Hoang, Van-Hai, Nguyen, Cong-Truong, La, Minh Thanh, Nam, Gibeom, Park, Hyun-Ju, Ann, Jihyae, Lee, Jeewoo, Kim, Yoon-Jae, Kim, Ji Young, Seo, Jae Hong

Volltext

The diarylheptanoid hirsutenone sensitizes chemoresistant ovarian cancer cells to cisplatin via modulation of apoptosis-inducing factor and X-linked inhibitor of apoptosis von Farrand, Lee, Kim, Ji Young, Byun, Sanguine, Im-aram, Akechai, Lee, Jihoon, Suh, Jeong-Yong, Lee, Ki-Won, Lee, Hyong Joo, Tsang, Benjamin K

Volltext

Phytochemicals : A Multitargeted Approach to Gynecologic Cancer Therapy von Farrand, Lee, Oh, Se-Woong, Song, Yong-Sang, Tsang, Benjamin K.

Volltext

Identification of a Dual Inhibitor of Janus Kinase 2 (JAK2) and p70 Ribosomal S6 Kinase1 (S6K1) Pathways von Byun, Sanguine, Lim, Semi, Mun, Ji Young, Kim, Ki Hyun, Ramadhar, Timothy R., Farrand, Lee, Shin, Seung Ho, Thimmegowda, N.R., Lee, Hyong Joo, Frank, David A., Clardy, Jon, Lee, Sam W., Lee, Ki Won

Volltext